Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Shire Pharmaceutical Development Ltd.

Home Clinical Trial Sponsors and OrganizationsShire Pharmaceutical Development Ltd.

Shire Pharmaceutical Development Ltd.

ACTIVE

United Kingdomfocusongaucher.co.ukSubsidiary

Part of Shire Plc

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

67

66 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

30

44.8%

Not Applicable

1

1.5%

Trial Status Distribution

Active, not recruiting

66

98.5%

Clinical Trials

Trials sponsored by this organization (67)

A study to compare treatment for hyperphosphataemia in childrensuffering from renal failure with a new product called Lanthanum oralpowder with an established treatment called calcium carbonate.

Active, not recruiting

Jun 201563 participants

A study to compare treatment for hyperphosphataemia in children suffering from renal failure with a new product called Lanthanum oral powder with an established treatment called calcium carbonate.

Active, not recruiting

Oct 201363 participants

A study to compare treatment for hyperphosphataemia in childrensuffering from renal failure with a new product called Lanthanum oralpowder with an established treatment called calcium carbonate.

Active, not recruiting

Aug 2013100 participants

A study to compare treatment for hyperphosphataemia in children suffering from renal failure with a new product called Lanthanum oral powder with an established treatment called calcium carbonate.

Active, not recruiting

Dec 201263 participants

A study to compare treatment for hyperphosphataemia in children suffering from renal failure with a new product called Lanthanum oral powder with an established treatment called calcium carbonate.

Active, not recruiting

Jul 2012100 participants

A study to compare treatment for hyperphosphataemia in children suffering from renal failure with a new product called Lanthanum oral powder with an established treatment called calcium carbonate.

Active, not recruiting

Jun 201263 participants

Clinical trial to compare Lisdexamfetamine Dimesylate and Atomoxetine Hydrochloride in Children and Adolescents aged 6-17 years with Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy

Active, not recruiting

May 2012262 participants

An extension study to enable patients to continue to receive Guanfacine Hydrochloride Extended Release tablets after completing either study SPD503-315 or SPD503-316.

Active, not recruiting

Mar 2012249 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials67
Approvals
News

Back to Organizations